-
-
-
-
-
-
-
BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26
-
-
-
-
-
-
-
BeiGene, Ltd. (ONC) Misses Q2 EPS by 4c, provides guidance
-
-
-
-
-
-
-
U.S. FDA Approves Tablet Formulation of BeOne’s BRUKINSA® for All Approved Indications
-
-
-
-
-
-
-
Oncolytics Biotech® Reports Highlights and Financial Results for Q4 and Year-End 2024
-
-
-
-
-
-
-
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
-
-
-
-
-
-
-
Oncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlights
-
-
-
-
-
-
-
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
-
1,207,345 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

